ERMINIA M GUARNERI

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease LA JOLLA, CA NPI 1013024868

General Payments — all program years on this page

$1,198.62

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 55
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $361.54 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $361.5416

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $28.761
2019 $17.021
2021 $121.936
2022 $234.5811
2023 $434.7920
2024 $361.5416

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086871755 Novartis Pharmaceuticals Corporation $24.26 01/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086871757 Novartis Pharmaceuticals Corporation $22.39 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086871769 Novartis Pharmaceuticals Corporation $29.41 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092709040 Boston Scientific Corporation $25.09 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096616518 Novo Nordisk Inc $23.67 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111590514 Amgen Inc. $21.69 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114685170 Exact Sciences Corporation $24.45 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114685176 Exact Sciences Corporation $23.54 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124063444 Vifor Pharma, Inc. $27.10 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129437020 Esperion Therapeutics, Inc. $21.71 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129437022 Esperion Therapeutics, Inc. $20.87 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132010274 PFIZER INC. $24.17 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132017696 PFIZER INC. $21.58 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139162982 RECORDATI_RARE_DISEASES_INC. $16.39 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153561361 Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.78 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154753844 Itamar Medical Inc $12.44 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.